So-Young International Inc (SY)
1.29
-0.03
(-2.27%)
USD |
NASDAQ |
May 13, 11:27
So-Young International Gross Profit Margin (Quarterly): 64.76% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.76% |
| September 30, 2023 | 62.99% |
| June 30, 2023 | 63.51% |
| March 31, 2023 | 63.33% |
| December 31, 2022 | 72.87% |
| September 30, 2022 | 70.92% |
| June 30, 2022 | 66.20% |
| March 31, 2022 | 64.51% |
| December 31, 2021 | 71.73% |
| September 30, 2021 | 79.22% |
| June 30, 2021 | 86.99% |
| March 31, 2021 | 85.44% |
| Date | Value |
|---|---|
| December 31, 2020 | 85.02% |
| September 30, 2020 | 84.78% |
| June 30, 2020 | 84.54% |
| March 31, 2020 | 76.39% |
| December 31, 2019 | 83.66% |
| September 30, 2019 | 82.18% |
| June 30, 2019 | 82.52% |
| March 31, 2019 | 82.33% |
| December 31, 2018 | 82.72% |
| September 30, 2018 | 85.74% |
| June 30, 2018 | 86.11% |
| March 31, 2018 | 86.99% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.99%
Minimum
Sep 2023
86.99%
Maximum
Jun 2021
75.34%
Average
76.39%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 59.05% |
| Zai Lab Ltd | 61.42% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.79% |
| Return on Assets | 0.64% |
| Return on Invested Capital | 0.79% |
| Profit Margin (Quarterly) | 4.48% |
| Operating Margin (Quarterly) | -1.26% |
| Return on Net Operating Assets | 1.63% |